Date:October 11, 2026
For generations, many of the world’s most advanced biologic medicines have been developed and manufactured far from Africa.
But what if Africa could build the capability to discover, develop, manufacture, and deliver its own life-changing biologics?
What if world-class biomanufacturing could be built on the continent — creating local expertise, strengthening health systems, and bringing critical therapies closer to the patients who need them?
At Bio Usawa, we believe that future is within reach.
In Rwanda, we are turning that belief into reality with the first monoclonal antibody manufacturing facility in Sub-Saharan Africa; a bold step toward a stronger, more self-sustaining African biopharmaceutical ecosystem.
This is where the journey begins. Dare to imagine. Then build it.
Bio Usawa is proud to celebrate Dr. Aida Habtezion, a member of our Board of Directors, on her new role as a Global Health Faculty Fellow at the Stanfor…
October 2026Bio Usawa Biotechnology today announced the launch of Bio Usawa Biotech Botswana (Pty) Ltd, marking an important milestone in the company’s mission to b…
October 2026Last week in Nairobi, our President and CEO, Dr. Menghis Bairu, met with Prof. Shaukat Abdulrazak, Principal Secretary for Science, Research and Innovat…
August 2026